Evidence map›Paper›PMID 38564070›Full record

ArticleAnnals of surgical oncology2024

ASO Author Reflections: Vasohibin-1 as a Biomarker for Chemotherapeutic Response in Patients with Advanced Bladder Cancer.

Minami Omura, Takeo Kosaka, Hiroaki Kobayashi, Keisuke Shigeta, Kazuhiro Matsumoto, Satoshi Hara, Eiji Kikuchi, Shuji Mikami, Hideyuki Saya, Yasufumi Sato and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Minami OmuraDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Takeo KosakaDepartment of Urology, Keio University School of Medicine, Tokyo, Japan. takemduro@gmail.com.ORCID http://orcid.org/0000-0002-4371-4594
Hiroaki KobayashiDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Keisuke ShigetaDepartment of Urology, Kawasaki Municipal Hospital, Kanagawa, Japan.
Kazuhiro MatsumotoDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Satoshi HaraDepartment of Urology, Kawasaki Municipal Hospital, Kanagawa, Japan.
Eiji KikuchiDepartment of Urology, St. Marianna University School of Medicine, Kanagawa, Japan.
Shuji MikamiDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.
Hideyuki SayaDivision of Gene Regulation, Institute for Advanced Medical Research, Graduate School of Medicine, Keio University, Tokyo, Japan.
Yasufumi SatoDepartment of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University, Miyagi, Japan.
Mototsugu OyaDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Keio University · JPKawasaki Municipal Hospital · JPSt. Marianna University School of Medicine · JPTohoku University · JP

Funding

Ministry of Education, Culture, Sports, Science and Technology of Japan #20H03817Ministry of Education, Culture, Sports, Science and Technology of Japan # 21K1957
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorCell Cycle ProteinsUrinary Bladder NeoplasmsHumansPrognosisBiomarkers, TumorCell Cycle ProteinsVASH1 protein, human

Identifiers

PMID38564070
OpenAlexW4393427218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.